Morgan Stanley (NY:MS)

CRISPR Therapeutics (NASDAQ:CRSP) CEO Sam Kulkarni outlined the company’s commercial and clinical priorities during a Morgan Stanley discussion, highlighting continued adoption of CASGEVY and expected...

Topics World Trade

CRISPR Therapeutics Eyes CASGEVY Growth, Year-End Pipeline Catalysts ↗

September 14, 2026

Merck & Co., Inc. (NYSE:MRK) Chairman and CEO Rob Davis said the company’s “transformation is underway,” citing progress across product launches, clinical data readouts, business development and its...

Topics Intellectual Property

Merck CEO Sees Pipeline Upside as Launches, Animal Health Drive Transformation ↗

September 14, 2026

Eli Lilly and Company (NYSE:LLY) is pursuing a broad obesity portfolio designed to address different patient needs across treatment initiation, maintenance, efficacy, tolerability and dosing...

Eli Lilly Eyes Obesity Access Expansion With Zepbound, Foundayo and Pipeline Bets ↗

September 14, 2026

What Happened? Shares of global professional services company Accenture (NYSE:ACN) jumped 5.2% in the afternoon session after Morgan Stanley raised its price...

Why Accenture (ACN) Stock Is Up Today

September 14, 2026

Johnson & Johnson Targets Double-Digit Growth as STELARA Faces Biosimilar Competition ↗

Topics Artificial Intelligence

September 14, 2026

Johnson & Johnson (NYSE:JNJ) executives said the company remains on track to grow through biosimilar competition for STELARA and expects its portfolio of medicines, medical devices and pipeline...

Pfizer (NYSE:PFE) Chairman and Chief Executive Officer Albert Bourla said the drugmaker has addressed several major headwinds that weighed on investor attention, including policy uncertainty, declining...

Topics ETFs Economy

Pfizer Says Major Headwinds Are Easing as Pipeline, Obesity Plans Take Center Stage ↗

September 14, 2026

Moderna (NASDAQ:MRNA) President Stephen Hoge said the company’s recently announced positive Phase III results for its investigational personalized cancer vaccine, intismeran, in adjuvant melanoma...

Topics Intellectual Property World Trade

Moderna’s Cancer Vaccine Win Fuels Broad Push Across Tumor Types ↗

September 14, 2026

Teva Pharmaceutical Industries (NYSE:TEVA) said its “Pivot to Growth” strategy has moved into its second phase, with management pointing to momentum in branded medicines, a stabilized generics...

Teva Pharmaceuticals Sees Pivot to Growth Accelerating on Branded Drugs, Biosimilars ↗

September 14, 2026

McKesson (NYSE:MCK) executives said the company’s first-quarter performance supported a higher full-year earnings outlook, citing broad-based growth across its North American Pharmaceutical, Oncology &...

McKesson Raises Outlook, Eyes Oncology Growth With Precision Medicine Deal ↗

September 14, 2026

Morgan Stanley Inclusive & Sustainable Ventures Announces 2026 Global Cohort of Innovators

September 14, 2026

From Morgan Stanley

Via Business Wire

Vertex Pharmaceuticals Eyes Renal Growth With Key PDUFA, Pipeline Catalysts Ahead ↗

September 14, 2026

Vertex Pharmaceuticals (NASDAQ:VRTX) is continuing to broaden its business beyond cystic fibrosis, with its renal medicine portfolio, rare endocrine assets and cell therapies among the company’s...

SpaceX will need substantial capital to pursue its various business ventures.

Billionaire David Einhorn Says SpaceX Is Making History, but Not in a Good Way ↗

September 14, 2026

On paper, a tenfold gain isn't far-fetched, but can Joby deliver it?

Topics Bonds Initial Public Offering

Joby Aviation Could Deliver 10x Returns for Patient Investors ↗

September 12, 2026

Morgan Stanley (NYSE:MS) has outperformed the market over the past 10 years by 7.4% on an annualized basis producing an average annual return of 20.97%. Currently, Morgan Stanley has a market...

Topics Economy

Here's How Much $100 Invested In Morgan Stanley 10 Years Ago Would Be Worth Today ↗

September 11, 2026

Via Benzinga

2 Stocks Cathie Wood Is Snapping Up at a Discount Right Now ↗

September 11, 2026

Several Ark funds recently bought the dip in Meta and Rocket Lab.

What Happened? Shares of athletic apparel company Under Armour (NYSE:UAA) jumped 1.9% in the afternoon session after Morgan Stanley resumed coverage of the s...

Topics Artificial Intelligence ETFs Earnings

Why Under Armour (UAA) Stock Is Trading Up Today

September 11, 2026

Morgan Stanley says Tesla Semi could add $80B in value as record $6.06 diesel strengthens the case for autonomous electric trucking.

Morgan Stanley Sees $80 Billion Tesla Semi Opportunity as Diesel Hits Record $6.06 ↗

September 11, 2026

Via Benzinga

Topics Energy

Tesla Semi Gets Boost From $6 Diesel; Morgan Stanley Says Earnings Potential 'Underappreciated' ↗

September 11, 2026

$6 diesel will help the Tesla Semi gain momentum, Morgan Stanley, which sees the big rig as an "underappreciated" earnings driver long term.

Via Investor's Business Daily

Topics Energy

BioMedNewsBreaks – Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) CEO to Participate in Morgan Stanley Global Healthcare Conference

September 10, 2026

Via Investor Brand Network

3 Overlooked Reasons Now Might Be the Time to Buy Ford Stock ↗

September 09, 2026

Ford offers investors a unique blend of legacy automotive stability and heavy investment in future ambitions. Here are three overlooked reasons Ford should intrigue investors.

As Anthropic's IPO Looms, This Small Financial Powerhouse Just Got Its First Underwriting Job ↗

Topics Electric Vehicles

September 09, 2026

This adds another market to its broad financial ecosystem.

Today, Sept. 9, 2026, investors are watching whether the autonomous agent can unlock a new revenue stream for the social platform.

Topics Artificial Intelligence Earnings Initial Public Offering

Stock Market Today, Sept. 9: Meta Surges Over 6.5% on Muse AI Agent Launch ↗

September 09, 2026

Brent topped $100 as Morgan Stanley warned oil and rates are the main risks to stocks, while traders bet fighting eases this month.

Topics Artificial Intelligence Stocks

Brent Tops $100 as Morgan Stanley Warns Oil, Rates Are ‘Main Risks’ to Stocks ↗

September 09, 2026

Via Benzinga

Ford Finally Sparked Wall Street Interest. But Is It All Hype? ↗

September 09, 2026

Ford has sparked Wall Street's interest in the legacy automaker after a near 50% surge in May, thanks to its battery systems focused on AI infrastructure needs.

What Happened? Shares of regional banking company Customers Bancorp (NYSE:CUBI) fell 2.7% in the afternoon session after Morgan Stanley analyst Brian Wilczyn...

Topics Artificial Intelligence

Why Customers Bancorp (CUBI) Stock Is Trading Lower Today

September 08, 2026

Google Cloud CEO Thomas Kurian said Alphabet (NASDAQ:GOOG) is seeing accelerating enterprise demand for its cloud infrastructure, artificial-intelligence products and cybersecurity offerings, citing...

Alphabet Conference: Google Cloud Sees Surging AI Demand, Bigger Enterprise Deals ↗

September 08, 2026

After Meta settled its youth social media lawsuit for up to $18 billion, Morgan Stanley expects a wave of new AI products and maintains a $775 price target on the stock.

Topics Artificial Intelligence

Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement ↗

September 08, 2026

What Happened? Shares of exercise equipment company Peloton (NASDAQ:PTON) fell 6.8% in the afternoon session after Morgan Stanley downgraded the company to a...

Topics Artificial Intelligence Lawsuit

Peloton (PTON) Stock Trades Down, Here Is Why

September 08, 2026

While short-term volatility may persist, many signs suggest UnitedHealth Group's turnaround remains in motion.

UnitedHealth Group Stock Is Up 39.4% in the Last 6 Months. How High Can It Go? ↗

September 08, 2026